Sign in
4

Changes in Ownership

Tango Therapeutics, Inc. Filed Acc 0000899243-21-033152

Options or other derivatives

  • Chief Executive Officer acquired 961,403 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Weber Barbara Chief Executive Officer 2021-08-12 Grant or award · Stock Option (Right to Buy) +961,403 $9.56 2031-08-12 961,403 961,403 D: show line 1 in the form
Loading xslF345X03/doc4.xml…